We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
The prognosis depends mainly on the kidney cancer subtype and the extent of the disease. In a localised disease, surgical treatment is usually successful. However, a follow-up must be done afterwards, as there is always a risk of relapse. If the disease spreads to other organs, the goal of treatment is to turn the cancer into a chronic disease and maintain quality of life.
No, there is currently no treatment after surgery shown to reduce the risk of relapse of the disease. However, the most recent studies seem to show that immunotherapy administration could be useful in this context. There are currently a number of different clinical trials in this field.
That understood as classical chemotherapy (the type which causes hair loss) is not useful in kidney cancer. For this reason, other treatments have been developed: mainly antiangiogenics and immunotherapy, which have shown a clear benefit in controlling these tumours.
This depends on numerous factors, including the kidney tumour subtype, the general condition of the patient, the disease symptoms and extension, other diseases the patient may have and the availability of different drugs or clinical trials. For this reason, a single recommendation cannot be made and the choice must be individualised based on patient characteristics.
During medical treatment, periodic imaging tests are carried out to monitor the evolution of the disease and to see if there is an improvement in the extent, stability and growth of these lesions. Depending on these results and tolerance to the treatment, the treatment is either continued or its regimen modified.
Your lifestyle depends on the symptoms the cancer produces and the side effects of the treatment. There are patients who have to reduce their activity and require more cures and others who can maintain an active life and even return to work.
Meritxell CasanovasServicio de Oncologia MédicaEnfermera
Mireia Musquera Felip
Oscar Reig TorrasMedical oncologist
Published: 1 February 2022
Updated: 1 February 2022
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.
Receive the latest updates related to this content.
Thank you for subscribing!
If this is the first time you subscribe you will receive a confirmation email, check your inbox
An error occurred and we were unable to send your data, please try again later.
Subscribe to the Newsletter of Clínic
Receive the latest news from our institution directly to your email.
Thanks for your subscription!
We have received your information. Check your inbox, in a few moments you will receive a confirmation email.
An error has occurred and we have not been able to send your data, please try again later.
More about assistance and health
Join our job pool
Hospital Clínic de Barcelona looks for talented professionals to cover job openings on a regular basis.